Clinical Trial Update: Head to Head Comparison of Azacitidine and Decitabine in Myelodysplastic Syndrome

View source ↗

Summary

A completed clinical trial comparing azacitidine with decitabine in myelodysplastic syndromes, sponsored by Seoul National University Hospital.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myelodysplastic Syndromes

Drugs mentioned

• Dacogen (decitabine)
• VIDAZA (AZACITIDINE)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Myelodysplastic Syndromes | Status: COMPLETED